introduction Decreasing international financial resources for HIV and increasing numbers of antiretroviral treatment (ART)-treated patients may jeopardise treatment continuity in low-income settings. Using data from the EVOLCam ANRS-12288 survey, this study aimed to document the prevalence of unplanned treatment interruption for more than 2 consecutive days (TI>2d) and investigate the associated individual and health care supply-related factors within the Cameroonian ART programme.
Introduction
In 2015, 17 million people living with HIV (PLWH) received antiretroviral treatment (ART), a better result than 2011 UNAIDS's '15 by 15' target [1, 2] . Despite this progress, world coverage was 46% at the end of 2015, and the epidemic continues to spread. Furthermore, ART coverage differs greatly worldwide. In 2015, coverage in Western and Central Africa only reached 28%, despite 20% of new HIV infections worldwide occurring in this region [3] . To meet the challenge of universal treatment and stop the spread of the epidemics, the international community's efforts are intensifying with new WHO guidelines recommending ART initiation upon HIV diagnosis [4] and the UNAIDS adoption of the '90-90-90' target [5] . However, these policies raise major difficulties for underequipped and underprepared health systems in sub-Saharan Africa. In particular, the objective of ensuring that at least 90% of ART-treated patients achieve viral suppression means overcoming two challenges: (i) optimising ART adherence and treatment continuity, thereby limiting the risk of virological failure and emergence of resistance to first-line therapies [6, 7] and (ii) guaranteeing that supply chain management systems ensure uninterrupted ART supply to avoid stock-outs and consequently treatment interruption (TI) [8] . While adherence to ART is a well-known driver of sustained virological suppression [9, 10] , several studies suggest that patients with unplanned TI of more than two consecutive days (hereafter TI>2d) are at higher risk of virological failure and drug-resistant viruses than patients with low-to moderate adherence [11, 12] . One recent study also showed that TI>2d, unlike low to -moderate adherence, had a significant detrimental impact on virological suppression during the maintenance phase (i.e. >1 year on ART) [13] . Research on ART adherence in sub-Saharan Africa to date has mostly focused on the impact of individual related factors, treatment regimen characteristics and patient-health care provider relationships [14, 15] . While more recent studies have suggested that structural deficiencies within health systems are also important factors in resource-limited settings [16, 17] , the role of health care supply-related factors in adherence and in TI remains poorly documented. The ANRS-12288 EVOLCam project helped us to study the prevalence of TI>2d in ART-treated PLWH followed up in 19 HIV services within Cameroon's ART programme and to investigate individual and health care supply-related correlates.
Methods

Setting
Cameroon is currently coping with a generalised HIV epidemic. The average prevalence in 2015 was 4.5% in the 15-49 year-old population [18] (6.1% in the Centre region (6.3% in Yaound e); 3.9% in the Littoral region (4.6% in Douala)) [19] . HIV care delivery was decentralised at the district level from 2005 onwards with the creation of HIV management units (HMU) in district hospitals. This complemented the supply of HIV care initially provided in accredited treatment centres (ATC) located in the national hospitals of the two main cities (Yaound e and Douala) and in the country's eight regional hospitals. The decentralisation of HIV care delivery together with the adoption of free ART in 2007 contributed to an eightfold increase in access between 2005 and 2014, leading to 27% coverage nationwide [20] . As demand for HIV care and treatment rapidly increased, the proportion of international funding in Cameroon's total national HIV budget decreased from 82% in 2009 to 60% in 2012, contributing to the reduction in almost 50% seen in the national HIV budget (from €43.8 million to €23.3 million) [21] .
Study design
ANRS-12288 EVOLCam was a cross-sectional mixed methods survey conducted in the Centre and Littoral regions of Cameroon between April and December 2014 to independently evaluate evolutions in the Cameroonian national ART programme through comparison with data from the ANRS-12116 EVAL survey conducted in 2006-2007 [17, 22] . A random selection procedure similar to that used for ANRS-12116 EVAL included eligible PLWH (≥21 years old and HIV diagnosed >3 months) attending the 19 participating HIV services. All participants provided written informed consent. Patient data collection included (i) a medical information form completed by caregivers; (ii) a face-to-face questionnaire administered by independent trained interviewers; and (iii) a blood sample for HIV viral load (VL) (only for patients treated >6 months) and CD4 cell count measurements. All blood samples were transported the same day and analysed by a reference HIV laboratory in Yaound e accredited by the WHO. HIV VL was measured using the Biocentric Generic HIV test (quantification threshold 300 copies/mL) or the Abbott RealTime HIV-1 quantitative assay (quantification threshold 40 copies/mL).
In addition, information about the 19 participating hospitals and their HIV services was obtained through interviews with hospital staff, in situ observations and facility activity reports.
ANRS-12288 EVOLCam was approved by the Ministry of Public Health in Cameroon and the Cameroonian National Ethics Committee.
Treatment interruption outcome
Treatment interruption for more than 2 consecutive days (TI>2d) during the previous 4 weeks was assessed based on patient self-report [13, 23] . A binary variable was created contrasting 'TI>2d' vs. 'No TI>2d' in the past 4 weeks (reference).
The choice of a 2-day interruption cut-off was motivated first by evidence in the literature that TI>2d is associated with virological failure [13, 24, 25] and second by the significant association that we found between detectable VL (>300 copies/mL) and TI>2d in patients on ART for at least physical and mental quality of life (score 0-100 calculated using the SF12 scale [26] ); stigma perception (score 0-8 calculated using the HIV Stigma Scale [27] ). 3 Clinical and ART-related characteristics: time since HIV diagnosis; time since ART initiation; tuberculosis (TB) co-infection (never, in the past (>1 year), currently treated or treated during the past year); and hospitalisation during the previous 3 months. 4 Patient-care system relationship: waiting room time before medical consultation on day of survey (<30 min vs. ≥30 min); interview with an adherence counsellor during the previous year; satisfaction with attention provided by doctor (6-point Likert scale); consultation with a traditional healer during the previous 3 months.
For health care supply-related factors, we collected the following data on the 19 participating services: location (Littoral vs. Centre region); legal status (public, private denominational, private for profit); size (small <80 beds, medium 80-300 beds and large >300 beds); type of HIV service HMU vs. ATC); number of years providing HIV services; number of ART-treated patients; equipment score (score 0-3 with 1 point by functional ECG, ultrasound or X Ray); presence of a functional therapeutic committee (at least one meeting per week); task shifting to nurses (i) for prescription renewals, (ii) for followup consultations; medical consultation cost >1000 FCFA (1.70 USD); financial support to PLWH (for transport, consultation or hospitalisation); occurrence during the previous year of ART stock-outs of at least one of the three most prescribed ART regimens in Cameroon. A regimen was considered out of stock if the following two conditions were met: (i) the three-molecule combination was unavailable and (ii) it was impossible to reconstitute the combination using separate single molecules.
Statistical analysis
The study population for the present analysis included patients receiving ART in the month preceding the survey. Descriptive analyses were performed on the whole study population and the two groups of patients of interest (i.e. reporting TI>2d vs. reporting no TI). We also provided descriptive analyses of the outcome according to the specific HIV service to illustrate inter-hospital variability.
Individual and health care supply-related factors associated with TI>2d were identified using a two-level multilevel logistic model for hierarchically structured data to take into account the correlation between individuals (level-1) within each hospital level unit (level-2) [28] . The relevance of using a multilevel model was confirmed by the intra-class variance estimation obtained in the null model which was significantly different from 0 (r 2 (u 0 ) = 0.3; P < 10 À3 ). Multivariate models were then constructed following the recommended modelling strategy [29] . Individual factors associated with TI>2d in univariate analyses with a 30% significance threshold were eligible for multivariate analysis. All health care supplyrelated factors were tested in the multivariate analysis to avoid the omission of important structural confounders. Using a stepwise backward selection procedure, we retained only significant individual and health care supply-related factors at a 5% threshold, except for the factor 'type of HIV service' which was kept in the model to control for heterogeneity between HIV services. In addition, interactions between individual and health care supply-related factors were tested. None was significant; therefore, no interaction was included in the final model. For both the null and the final models, we produced the intra-class variance and the intra-class correlation coefficient (ICC), the latter representing the proportion of the intra-class variance compared with the total variance, as well as the log-likelihood values (for the final model only). Analyses were performed using SAS 9.4 software (SAS Institute Inc., Cary, NC, USA).
Results
Health care supply-related characteristics Table 1 describes the main characteristics of the participating hospitals for the whole sample (n = 19) and according to location (Littoral, n = 8 vs. Centre region, n = 11). Approximately, two-thirds (13/19) were public hospitals while one-quarter (5/19) had a non-profit denominational status. Overall, half were medium-sized (80-300 beds), HIV services had been operating for approximately 10 years, the average number of patients registered was 2243 PLWH and few HIV services (6/19) provided financial support to their patients. All these characteristics were similar in both regions. In addition, more than half of the HIV services had a functional therapeutic committee (12/19) , mostly those located in the Centre region (9/11 vs. 3/8 in the Littoral). Task shifting of follow-up visits to nurses was practiced in approximately two-thirds of services in both regions but task shifting of ART prescription renewals to nurses was twice as frequent in the Centre region (8/11 vs. 3/8 in the Littoral). Finally, approximately half of all 19 HIV services had stock-outs of at least one of the three most prescribed ART regimens during the previous 12 months, with 7/11 and 3/8 of HIV services in the Centre and Littoral regions being affected, respectively.
Study population characteristics
Among the 2357 eligible patients approached, 2165 (91.9%) agreed to participate in the survey and 2138 (98.8%) filled out the questionnaire (global response rate of 90.7%). Among them, 1939 (90.7%) had received ART during the month preceding the survey. Due to missing information for some variables in the multivariate analysis, 54 (2.8%) observations were excluded. These were not significantly different from those retained ¶Financial support for transport, hospitalization or consultation **The three most prescribed ART regimens in Cameroon are TDF+3TC+EFV; AZT+3TC+NVP; and TDF+3TC+NVP. A regimen was considered out of stock if (i) the three-molecule combination was not available and (ii) it was not possible to reconstitute the combination using separate single molecules.
regarding gender, age, living in a couple, educational level, having children, physical and mental quality of life and delay since ART initiation >1 year. Analyses were therefore performed on the remaining 1885 (i.e. the study population).
The main characteristics of the study population were as follows (Table 2) : mean age was approximately 42 years; 74% were women; 88% had children; 35% had completed only primary school or less and 64% had an economic activity. Although most patients (60%) reported having a main partner, 13% had not disclosed their HIV status to him/her and 7% reported little or no support from him/her. With respect to clinical characteristics, mean time since HIV diagnosis was 4.9 years, 80% of patients were ART-treated for more than 1 year, 12% were TB co-infected (treated currently or during the previous year) and 11% had been hospitalised in the previous 3 months. Finally, patient-care system relationship data showed that 83% of patients were very satisfied with the attention their doctor provided and a minority (5%) had consulted a traditional healer in the previous 3 months.
Descriptive analysis of treatment interruption >2 days
Among the 1885 study patients, 403 (21%) reported TI>2d during the previous 4 weeks. Figure 1 shows the great variability in TI>2d between HIV services, from approximately 5% (HIV service number 15 in the Littoral region) to almost 40% (HIV services number 4 and 7 in the Centre region). HIV services with the lowest proportions of TI>2d (<10%) were all located in the Littoral (HIV services number 15, 16 and 19) .
Factors associated with TI>2d
For individual factors, results of univariate and multivariate analyses are presented in Table 2 ) were also at lower risk of TI>2d than their respective counterparts. On the contrary, PLWH who consulted a traditional healer during the previous 3 months were at higher risk of TI>2d (aOR [95% CI] = 2.09 [1.31-3.33], P = 0.002). The following individual variables were significantly associated with a lower risk of TI>2d in univariate analysis (5% threshold) but no longer significant in multivariate analysis ( Table 2) : age; disclosure to main partner; no support from main partner (because of no disclosure or being single) and mental quality of life. Conversely, alcohol consumption ≥4 glasses on one occasion was significantly associated with a higher risk of TI>2d in univariate analysis.
With regard to health care supply-related factors, the multivariate model showed that PLWH attending HIV services in the Centre region were approximately twice as likely to report TI>2d as those in the Littoral region were less likely to report TI>2d. On the contrary, being followed up in hospitals reporting stock-outs of at least one of the three most prescribed ART regimens during the previous year was significantly associated with a higher risk for TI>2d (aOR [95% CI] = 1.54 [1.00-2.37], P = 0.048).
The ICC obtained in the null model highlighted that the variance related to health care facility level represented 8.4% of the total variance of TI>2d (bottom of Table 2 ). Taking into account both individual and health care supply-related factors provided an ICC value of 2.1% in the final multivariate model. This indicates that our variables were able to explain the greatest part of the variance at the health care facility level.
Discussion
This study presents findings on ART interruption for more than two consecutive days (TI>2d) among HIVpositive individuals receiving ART within accredited HIV services of the Cameroonian ART programme in the Littoral and Centre regions. Our results showed a worrying prevalence of TI>2d in almost 21% of the study population. Furthermore, we observed large disparities between HIV services, with prevalences of TI>2d varying between approximately 5% and 40%, the highest prevalence values being concentrated in the Centre region. Although not directly comparable, these figures were almost twice as high as those observed in the 2006-2007 ANRS-12116 EVAL survey (11.1% overall in the six regions studied [17] and 12.8% in Yaound e [16] ). In addition, the present data showed that 10 of the 19 participating HIV services (52.6%) recorded stock-outs of at least one of the three most prescribed ART regimens during the previous year. Similar difficulties were shown in another study in Cameroon that reported ART stock-outs in 11 of 13 health care facilities monitored for HIV drug resistance in the Centre and Littoral regions [30] . Our results are also in line with other studies conducted in Cameroon, Malawi and Côte d'Ivoire [17, [31] [32] [33] [34] where ART stock-outs were reported by patients as the main reason for missing doses. Besides its direct detrimental consequences on treatment availability, the qualitative data collected during interviews from patients and caregivers highlighted the indirect harmful effects of stock-outs. More specifically, they underlined the contradictions generated, on the one hand, by caregivers emphasising the need to maintain a high adherence level without interruptions to optimise treatment efficacy and, on the other hand, the reality of stock-outs. In these circumstances, caregivers reported developing various strategies to cope with stock-outs: switching regimens to use an available similar class drug, splitting delivered doses or sending patients to another HIV service. These strategies were also described in a study conducted in 20 Tanzanian HIV district clinics [35] . Furthermore, ART supply stock-outs and their deleterious consequences on adherence have been reported in several sub-Saharan countries [36, 37] . ART stock-outs may also have an indirect negative effect on virological failure, especially during the treatment maintenance phase (i.e. >1 year on ART) as suggested by one longitudinal study conducted among ART-naive patients in Cameroon [13] . In our study, 80% of patients were receiving ART >1 year, and detectable VL (>300 copies/mL) was significantly associated with TI>2d among patients treated by ART since at least 6 months, suggesting that ART stock-outs observed within the Cameroonian ART programme may also have an indirect harmful impact on virological suppression.
Other health care supply-related factors of TI included the location and size of participating hospitals. As regards location, our results highlight that patients followed up in HIV services in the Centre region were approximately twice as likely to report TI>2d. The fact that this association was still significant in multivariate analysis, after accounting for differences in health care supply characteristics (like ART stock-outs which were more frequent in the Centre), suggests that this variable may capture non-observed health care facility characteristics or regional differences in the resources allocated to HIV services and/or in the organisation and management of these services. Our results also confirm those obtained during the 2006-2007 ANRS-12116 EVAL survey regarding the negative impact of HIV care provided in [17, [38] [39] [40] [41] [42] . Furthermore, PLWH, unsatisfied with the attention their doctor provided, were more likely to interrupt their treatment as were those who had consulted a traditional healer during the previous 3 months. As with any chronic disease, our results suggest that a relationship of trust between health care providers and patients is essential for the continuity of care and treatment [16, 40, 43, 44] . Consulting traditional healers has also been reported in several studies: it may represent a more accessible and cheaper alternative to academic medicine, but may also reflect a desire to distance oneself from modern medicine [24, 32, 41, 45] . Our study has limitations. First, ANRS-12288 EVOLCam was conducted in only two of the 10 regions in Cameroon (the Centre and the Littoral). These two regions were selected because they have the highest HIV prevalence in the country and most ART-treated patients reside there. Our results are therefore not representative of the overall situation in the country. However, as we selected a representative sample of existing HIV services in both regions and used a random selection procedure for inclusion, our study sample is representative of the HIV-positive population treated by ART within the Cameroonian ART programme in these two regions. Second, treatment interruption was assessed using patients' self-reports, which may have induced recall and social desirability biases, as patients may have under-reported missing doses. However, any such bias was limited by the administration of face-to-face questionnaires by independent interviewers and the use of a validated adherence scale [46] specifically constructed to address this issue. In a sensitivity analysis, we used the adherence score computed over the previous 4 days to identify patients with only 1-2 days of treatment interruption. This group was excluded from the sensitivity analysis to test the robustness of a cut-off of more than 2 days. The same associated factors were found, except for the ART stock-out variable which was no more significant at the 5% level, but only at the 10% level (aOR [95% CI] = 1.51 [0.95-2.40], P = 0.08). In addition, the availability of VL measurements for patients on ART for at least 6 months enabled us to confirm the association between virological suppression and our outcome.
Despite these limitations, our survey provides quite a comprehensive picture of the HIV population receiving ART in the Cameroonian ART programme in the Centre and Littoral regions in 2014. Difficulties within the Cameroonian drugs supply system have been reported since 2008 [47] and continue today, highlighting continued challenges regarding financial mechanisms, human resources and drugs management. Investigations into the causes of persistent stock-outs and the involvement of patient associations to complement government monitoring mechanisms are two urgent interventions to assess supply chain efficiency.
Conclusions
Our results will inform health policy decision-makers about the scale and factors associated with treatment interruption within the Cameroonian ART programme. In particular, they highlight two important issues: first, the suboptimal performance of the existing programme, with a worrying proportion of patients reporting TI>2d (21%) and large disparities in TI>2d prevalence between HIV services and second, the deleterious effect of ART stock-outs on this outcome. The effectiveness of Cameroon's ART programme and the realisation of the '90-90-90' objectives may be seriously jeopardised if effective measures to limit treatment interruption like ART supply management measures are not urgently implemented.
